2026 Sanjeev Mariathasan: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	58	12869	11838	5475	4897	199	38770

Overview

Sanjeev Mariathasan is affiliated with Genentech in the United States and has a research focus primarily situated in the fields of Medicine and Immunology and Microbiology. Their work extensively covers oncology, immunology, surgery, and pulmonary and respiratory medicine, with significant contributions to cancer research.

The scientist's research centers on several main topics:

Cancer Immunotherapy and Biomarkers
Bladder and Urothelial Cancer Treatments
Immune Cell Function and Interaction
Urinary and Genital Oncology Studies
Cancer Genomics and Diagnostics
Immune cells in cancer
Prostate Cancer Treatment and Research

Some of their most cited recent papers include:

"Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial" (2020) published in The Lancet
"Peripheral T cell expansion predicts tumour infiltration and clinical response" (2020) published in Nature
"ctDNA guiding adjuvant immunotherapy in urothelial carcinoma" (2021) published in Nature
"Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade" (2020) published in Cancer Cell
"High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade" (2020) published in Nature Medicine

The scientist has frequently published in high-impact journals. Notable publication venues include:

Journal of Clinical Oncology
Cancer Research
Nature
Nature Medicine
Cancer Immunology Research

Collaborations are a significant part of their research, with frequent coauthors including:

Romain Banchereau
Thomas Powles
Kobe Yuen
Ira Mellman
Edward E. Kadel

Best Publications

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Sanjeev Mariathasan;Shannon J. Turley;Dorothee Nickles;Alessandra Castiglioni

5263
Citations
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

Jonathan E Rosenberg;Jean Hoffman-Censits;Tom Powles;Michiel S van der Heijden

4667
Citations
Cryopyrin activates the inflammasome in response to toxins and ATP

Sanjeev Mariathasan;David S. Weiss;Kim Newton;Jacqueline McBride

3566
Citations
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

Sanjeev Mariathasan;Kim Newton;Denise M. Monack;Domagoj Vucic

2133
Citations
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

Thomas Powles;Ignacio Durán;Michiel S van der Heijden;Yohann Loriot

1552
Citations
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

Pietro De Togni;Joseph Goellner;Nancy H. Ruddle;Philip R. Streeter

1237
Citations
Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Sanjeev Mariathasan;Denise M. Monack

1095
Citations
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b

Kurt Wolfgang Bachmaier;Connie Krawczyk;Ivona Kozieradzki;Young Yun Kong

799
Citations
Novel antibody–antibiotic conjugate eliminates intracellular S. aureus

Sophie M. Lehar;Thomas Pillow;Min Xu;Leanna Staben

772
Citations
Peripheral T cell expansion predicts tumour infiltration and clinical response

Thomas D. Wu;Shravan Madireddi;Patricia E. de Almeida;Romain Banchereau

754
Citations
SELECTION OF THE T CELL REPERTOIRE

Eric Sebzda;Sanjeev Mariathasan;Toshiaki Ohteki;Russell Jones

680
Citations
Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella

Petr Broz;Kim Newton;Mohamed Lamkanfi;Sanjeev Mariathasan

669
Citations
Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2.

H Molina;V M Holers;B Li;Y Fung

598
Citations
The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection.

Dario S Zamboni;Koichi S Kobayashi;Koichi S Kobayashi;Tiana Kohlsdorf;Yasunori Ogura

591
Citations
Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis

Sanjeev Mariathasan;David S. Weiss;Vishva M. Dixit;Denise M. Monack

515
Citations
Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers.

Mitsuru Matsumoto;Sanjeev Mariathasan;Moon H. Nahm;Ferenc Baranyay

485
Citations
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.

Thomas Powles;Mark Kockx;Alejo Rodriguez-Vida;Ignacio Duran

485
Citations
A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide

Li Chung Hsu;Syed R. Ali;Shauna McGillivray;Ping Hui Tseng

483
Citations
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.

Thomas Powles;Zoe June Assaf;Nicole Davarpanah;Romain Banchereau

424
Citations
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade

Robert J. Motzer;Romain Banchereau;Habib Hamidi;Thomas Powles

371
Citations